Author

David Hudesman

Observed name: D Hudesman

Institutions: NYU Langone Health, New York University

Observed institutions: NYU Langone Health, New York University

OpenAlex ID: A5123458089

AVB-114 Demonstrates Clinical Benefit in Persistent Crohn's Perianal Fistulas: Randomized Cohort Results From the Multicenter STOMP2 Trial

2026 · David A. Schwartz, Eric Dozois, et al. · The American Journal of Gastroenterology · 1

DOP008 Expanded Primary Analysis of the Randomized, Wait-List Controlled STOMP2 Trial Evaluating AVB-114 in Persistent Crohn’s Perianal Fistulas

2026 · D Schwartz, E Dozois, et al. · Journal of Crohn s and Colitis · 1

Defining Moderate Disease Activity and Severity in Crohn’s Disease and Ulcerative Colitis

2026 · Chiahung Chou, Marie Sanchirico, et al. · Journal of Clinical Gastroenterology

P0777 Dual targeted therapy with vedolizumab and tofacitinib in patients with Ulcerative Colitis: Initial results from the phase 4 ExiGem study

2026 · A Yarur, E Barnes, et al. · Journal of Crohn s and Colitis

Works count: 4

Citation count: 2

H-index: 1

I10-index: